Shandong Luoxin Pharmaceutical Group — Post-IPO Equity
Shandong Luoxin Pharmaceutical Group raised $18.1M in a Post-IPO Equity round. View investors, financials, and press on Fsome.
Round Details
- Funded Company
- Shandong Luoxin Pharmaceutical Group
- Round Type
- Post-IPO Equity
- Amount Raised
- $18.1M
- Announced
- July 16, 2025
Canonical: https://fsome.com/funding/shandong-luoxin-pharmaceutical-group-post-ipo-equity-6153626 · For the full investor list, press references, and related rounds, please enable JavaScript.